SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-005484
Filing Date
2018-03-13
Accepted
2018-03-13 16:59:21
Documents
3
Period of Report
2018-03-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20180313.htm 8-K 77557
2 EX-99.1 xene-ex991_37.htm EX-99.1 13378
3 GRAPHIC g201803131958281555618.jpg GRAPHIC 5126
  Complete submission text file 0001564590-18-005484.txt   99389
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 18687188
SIC: 2834 Pharmaceutical Preparations